2 of the best FTSE 100 stocks to buy today

The FTSE 100 index is in the red today, but not all stocks are doing badly. These two, for instance, are among the biggest gainers. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It may be an awful day for the markets, but not all stocks are losers. There are at least a handful of FTSE 100 stocks that are making fairly decent gains. No prizes for guessing which these are though. These are the classic defensive shares investors buy when there is some serious economic and stock market uncertainty around. 

These include the healthcare biggie and Covid-19 vaccine developer AstraZeneca (LSE: AZN) and precious metals miner Polymetal International (LSE: POLY). While the AstraZeneca stock is up some 3% as I write, Polymetal International is up 1.4%. If stock markets keep falling, I think I can be fairly certain that both stocks will have further upside to them. 

AstraZeneca is a dependable healthcare stock

Being a healthcare company, AstraZeneca’s treatments are in demand even during times of economic slowdowns. Additionally, the fact that they are successful and widely accepted makes it an even more coveted stock to hold. This shows up in its financials too. This makes AZN a far safer place for me to park my funds than real estate and industrial metals stocks that are vulnerable to withdrawal of fiscal stimulus by governments. 

That said, it is not devoid of its own, very particular, challenges. For instance, the company was in disagreement with the European Union earlier this year regarding the distribution of vaccines. Also there were questions around the efficacy of the vaccine itself. Despite all this, it has always been a pricey stock. Its current price-to-earnings (P/E) ratio is at 39 times, and this is among the lowest I have seen since I started tracking the stock. 

Polymetal International is a precious metals play

Polymetal International mines gold and silver, both of which see rising demand during uncertain times. Last year was a good example of this. As stock markets crashed, gold prices rallied. They only slowed their upward climb when the economic outlook improved. 

But I like the stock because of its performance even before the gold price rally started. Since 2017, the company has seen a consistent rise in both its revenues and profits. In other words, even if it benefits from higher gold prices, its performance is not dependent on them, which makes it a far more dependable stock to hold than many others. It also has a dividend yield of a high 7.4%. 

The only catch to the stock, I feel, is the share price crash it has seen. In the last year, it has fallen by more than 25%. This is a big downer, but then again it is potentially good for portfolio de-risking when there is a slowdown. Also, I think that as its share price has fallen so much, that it was only a matter of time before it started rising. 

Would I buy these FTSE 100 shares?

I bought both stocks a while ago. And this is only partly because of their defensive nature. I just really liked their performance. And over time, if it is maintained, it only goes in the stocks’ favour. They are still good buys, in my view.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh owns shares of AstraZeneca and Polymetal International. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What might 2025 have in store for the Aviva share price? Let’s ask the experts

After a rocky five years, the Aviva share price has inched up in 2024. And City forecasters reckon we could…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Trading around an 11-year high, is Tesco’s share price still significantly undervalued?

Although Tesco’s share price has risen a lot in the past few years, it could still have significant value left…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£11,000 in savings? Investors could consider targeting £5,979 a year of passive income with this FTSE 250 high-yield gem!

This FTSE 250 firm currently delivers a yield of more than double the index’s average, which could generate very sizeable…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

Does a 9.7% yield and a P/E under 10 make the Legal & General share price a no-brainer?

With a very high dividend yield and a falling P/E forecast, could the Legal & General share price really be…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

This growth stock is up 2,564% over 6 months! Is this FOMO?

This growth stock has experienced an incredible appreciation in its share price. It’s not a meme stock, but investors might…

Read more »

Investing Articles

This bank’s dividend yield will grow to 6.9% in 2026! And analysts say its undervalued

Analysts say this FTSE 100 stock’s dividend yield will continue to rise over the medium term. With the stock also…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Can we justify the red-hot Tesla share price?

It might just be FOMO, but the Tesla share price is going from strength to strength. Dr James Fox takes…

Read more »

Investing Articles

UK stocks are 52% discounted, says Goldman Sachs

With UK stocks staggeringly cheap right now, this Fool took the chance to add one unloved FTSE 100 share to…

Read more »